CLRB stock

Cellectar Biosciences Inc (CLRB) financials · $20.8M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Cellectar Biosciences Inc (CLRB) $20.8M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$23.0M-$51.8M
Net Income-$21.8M-$44.6M
EPS (Diluted)-$8.35-$1.40
Cached annual balance sheet
LineFY2025FY2024
Total Assets$15.0M$25.5M
Current Assets$14.0M$24.3M
Cash & Equivalents$13.2M$23.3M
PP&E$549.4K$757.1K
Total Liabilities$5.06M$9.80M
Current Liabilities$4.75M$9.39M
Shareholders' Equity$8.54M$14.3M
Retained Earnings-$269.1M-$247.3M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$23.1M-$47.6M
CapEx$5.88K$104.2K
Investing Cash Flow-$5.88K-$104.2K
Financing Cash Flow$13.0M$61.4M
Net Change in Cash-$10.1M$13.7M
Free Cash Flow-$23.1M-$47.7M
These statements as JSON? API free 100/day

FAQ

What is CLRB P/E and revenue?

Cellectar Biosciences Inc (CLRB) $20.8M cap.

What is CLRB revenue?

CLRB income-statement cache has no revenue figure yet.

Is CLRB profitable?

Cellectar Biosciences Inc last cached net income is -$21.8M (FY2025).

What are CLRB total assets?

Cellectar Biosciences Inc last cached total assets are $15.0M (FY2025).

What is CLRB free cash flow?

Cellectar Biosciences Inc last cached free cash flow is -$23.1M (FY2025).

Not investment advice. Cached statements, not a live tape.